Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertility Preservation | 4 | 2023 | 18 | 1.570 |
Why?
|
| Oocytes | 10 | 2020 | 221 | 1.360 |
Why?
|
| Granulosa Cells | 6 | 2020 | 32 | 1.300 |
Why?
|
| Follicle Stimulating Hormone | 6 | 2020 | 147 | 1.060 |
Why?
|
| Anti-Mullerian Hormone | 2 | 2018 | 10 | 0.810 |
Why?
|
| Cumulus Cells | 6 | 2019 | 7 | 0.680 |
Why?
|
| Ovulation Induction | 5 | 2014 | 33 | 0.660 |
Why?
|
| Abortion, Spontaneous | 1 | 2018 | 66 | 0.620 |
Why?
|
| Somatomedins | 1 | 2017 | 28 | 0.600 |
Why?
|
| Luteinizing Hormone | 4 | 2014 | 167 | 0.550 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2012 | 179 | 0.530 |
Why?
|
| Ovary | 3 | 2012 | 258 | 0.480 |
Why?
|
| Infertility, Female | 3 | 2014 | 93 | 0.450 |
Why?
|
| Glycoproteins | 2 | 2012 | 234 | 0.440 |
Why?
|
| Oogenesis | 3 | 2012 | 45 | 0.430 |
Why?
|
| Reproduction | 1 | 2011 | 195 | 0.370 |
Why?
|
| Insulin-Like Growth Factor II | 3 | 2020 | 33 | 0.360 |
Why?
|
| Piperazines | 1 | 2011 | 272 | 0.360 |
Why?
|
| Follicular Fluid | 6 | 2016 | 10 | 0.360 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2008 | 5 | 0.340 |
Why?
|
| Pyrimidines | 1 | 2011 | 370 | 0.330 |
Why?
|
| Cholestasis | 1 | 2008 | 47 | 0.330 |
Why?
|
| Ovarian Follicle | 4 | 2017 | 72 | 0.310 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2004 | 15 | 0.280 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 2 | 2004 | 19 | 0.280 |
Why?
|
| Receptors, Adrenergic, beta-2 | 3 | 2002 | 36 | 0.270 |
Why?
|
| Chorionic Gonadotropin | 4 | 2019 | 72 | 0.270 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 107 | 0.270 |
Why?
|
| Cells, Cultured | 7 | 2020 | 2818 | 0.260 |
Why?
|
| Growth Differentiation Factor 9 | 3 | 2020 | 3 | 0.250 |
Why?
|
| Bone Morphogenetic Protein 15 | 3 | 2020 | 3 | 0.250 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 1920 | 0.240 |
Why?
|
| Fertilization in Vitro | 3 | 2019 | 55 | 0.230 |
Why?
|
| Fertility | 1 | 2023 | 115 | 0.230 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2014 | 103 | 0.220 |
Why?
|
| Female | 22 | 2020 | 44534 | 0.210 |
Why?
|
| Aromatase | 2 | 2019 | 12 | 0.210 |
Why?
|
| Oocyte Retrieval | 2 | 2012 | 7 | 0.200 |
Why?
|
| Cell Differentiation | 3 | 2017 | 1458 | 0.190 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2019 | 44 | 0.190 |
Why?
|
| Pregnancy | 5 | 2018 | 2894 | 0.190 |
Why?
|
| Fertilization | 2 | 2018 | 40 | 0.180 |
Why?
|
| Humans | 24 | 2023 | 86645 | 0.180 |
Why?
|
| Transgender Persons | 1 | 2022 | 95 | 0.180 |
Why?
|
| Meiosis | 3 | 2016 | 80 | 0.180 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 2360 | 0.180 |
Why?
|
| Signal Transduction | 7 | 2019 | 3241 | 0.180 |
Why?
|
| Culture Media, Conditioned | 1 | 2020 | 104 | 0.180 |
Why?
|
| Luteal Cells | 1 | 2019 | 2 | 0.180 |
Why?
|
| Receptors, LH | 1 | 2019 | 7 | 0.180 |
Why?
|
| Epidermal Growth Factor | 2 | 2010 | 119 | 0.180 |
Why?
|
| Sp1 Transcription Factor | 1 | 2019 | 19 | 0.170 |
Why?
|
| Amphiregulin | 3 | 2014 | 7 | 0.150 |
Why?
|
| Biomarkers | 2 | 2017 | 1718 | 0.150 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2022 | 50 | 0.140 |
Why?
|
| Oncogene Protein v-akt | 1 | 2015 | 21 | 0.130 |
Why?
|
| Ovulation | 2 | 2011 | 68 | 0.130 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 21 | 0.120 |
Why?
|
| Spermatozoa | 1 | 2014 | 62 | 0.120 |
Why?
|
| Pregnancy Rate | 1 | 2014 | 20 | 0.120 |
Why?
|
| Hormone Antagonists | 1 | 2014 | 20 | 0.120 |
Why?
|
| RNA, Messenger | 5 | 2019 | 1981 | 0.120 |
Why?
|
| Cyclic GMP | 1 | 2014 | 58 | 0.120 |
Why?
|
| Cyclic AMP | 4 | 2020 | 273 | 0.120 |
Why?
|
| Sperm Injections, Intracytoplasmic | 2 | 2012 | 8 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2002 | 222 | 0.120 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 188 | 0.120 |
Why?
|
| Progesterone | 2 | 2010 | 110 | 0.110 |
Why?
|
| Metaphase | 1 | 2012 | 25 | 0.110 |
Why?
|
| Imatinib Mesylate | 1 | 2011 | 126 | 0.100 |
Why?
|
| Cryopreservation | 1 | 2011 | 69 | 0.100 |
Why?
|
| Adult | 9 | 2022 | 25648 | 0.100 |
Why?
|
| Epiregulin | 1 | 2010 | 2 | 0.100 |
Why?
|
| Betacellulin | 1 | 2010 | 3 | 0.100 |
Why?
|
| EGF Family of Proteins | 1 | 2010 | 4 | 0.100 |
Why?
|
| Endometrium | 1 | 2010 | 48 | 0.100 |
Why?
|
| Benzamides | 1 | 2011 | 229 | 0.090 |
Why?
|
| Endometriosis | 1 | 2010 | 58 | 0.090 |
Why?
|
| Gentamicins | 1 | 2010 | 19 | 0.090 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 173 | 0.090 |
Why?
|
| Chorioamnionitis | 1 | 2010 | 15 | 0.090 |
Why?
|
| Mitosis | 1 | 2010 | 153 | 0.090 |
Why?
|
| Phosphorylation | 5 | 2004 | 1106 | 0.090 |
Why?
|
| Infertility | 1 | 2009 | 37 | 0.090 |
Why?
|
| Primary Cell Culture | 2 | 2020 | 72 | 0.080 |
Why?
|
| Smad3 Protein | 2 | 2019 | 15 | 0.080 |
Why?
|
| Smad2 Protein | 2 | 2019 | 17 | 0.080 |
Why?
|
| Hormones | 1 | 2009 | 141 | 0.080 |
Why?
|
| Animals | 11 | 2014 | 26582 | 0.080 |
Why?
|
| Pregnancy Trimester, First | 1 | 2008 | 63 | 0.080 |
Why?
|
| CHO Cells | 3 | 2004 | 187 | 0.080 |
Why?
|
| Risk Factors | 1 | 2018 | 5417 | 0.080 |
Why?
|
| Cricetinae | 3 | 2004 | 560 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2014 | 7993 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2008 | 247 | 0.070 |
Why?
|
| Enzyme Activation | 3 | 2004 | 692 | 0.070 |
Why?
|
| Prognosis | 2 | 2011 | 3680 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1961 | 0.070 |
Why?
|
| Adenylyl Cyclases | 2 | 2004 | 100 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2004 | 8 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 746 | 0.060 |
Why?
|
| ErbB Receptors | 2 | 2014 | 485 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2016 | 1578 | 0.060 |
Why?
|
| Adenylate Cyclase Toxin | 1 | 2002 | 14 | 0.050 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2002 | 26 | 0.050 |
Why?
|
| Pertussis Toxin | 1 | 2002 | 31 | 0.050 |
Why?
|
| Intention | 1 | 2022 | 51 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2002 | 146 | 0.050 |
Why?
|
| Parenting | 1 | 2022 | 67 | 0.050 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2000 | 19 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1014 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2020 | 224 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2000 | 254 | 0.040 |
Why?
|
| Adolescent | 1 | 2011 | 8982 | 0.040 |
Why?
|
| Steroids | 1 | 2019 | 177 | 0.040 |
Why?
|
| Time Factors | 3 | 2014 | 5210 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1997 | 73 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 1621 | 0.040 |
Why?
|
| Ligands | 2 | 2012 | 433 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1997 | 190 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 101 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 712 | 0.030 |
Why?
|
| Middle Aged | 2 | 2010 | 25028 | 0.030 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2014 | 8 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 2014 | 37 | 0.030 |
Why?
|
| Adult Stem Cells | 1 | 2014 | 30 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 196 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 2501 | 0.030 |
Why?
|
| Testis | 1 | 2014 | 152 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 378 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 268 | 0.030 |
Why?
|
| Blastocyst | 1 | 2012 | 34 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 679 | 0.030 |
Why?
|
| Nucleotides, Cyclic | 1 | 2011 | 10 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2004 | 280 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2012 | 281 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 376 | 0.020 |
Why?
|
| COS Cells | 2 | 2002 | 166 | 0.020 |
Why?
|
| Gap Junctions | 1 | 2011 | 142 | 0.020 |
Why?
|
| Peritoneal Diseases | 1 | 2010 | 15 | 0.020 |
Why?
|
| Kidney | 1 | 1997 | 1241 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 115 | 0.020 |
Why?
|
| Child | 1 | 2022 | 6928 | 0.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2010 | 18 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2010 | 70 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 244 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2012 | 459 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2009 | 16 | 0.020 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2009 | 7 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2010 | 256 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 543 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 379 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 1924 | 0.020 |
Why?
|
| Prolactin | 1 | 2009 | 88 | 0.020 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2009 | 50 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 989 | 0.020 |
Why?
|
| Models, Biological | 2 | 2009 | 1749 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 879 | 0.020 |
Why?
|
| Estradiol | 1 | 2009 | 252 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 916 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 296 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 596 | 0.020 |
Why?
|
| Testosterone | 1 | 2009 | 271 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2010 | 729 | 0.020 |
Why?
|
| Protein Binding | 2 | 2002 | 1456 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 2330 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 1284 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1805 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2010 | 1823 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1384 | 0.020 |
Why?
|
| Plasmids | 1 | 2004 | 287 | 0.020 |
Why?
|
| Transfection | 1 | 2004 | 896 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2002 | 59 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 68 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 74 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2002 | 145 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2002 | 141 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 143 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 1098 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2000 | 67 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2000 | 117 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 696 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 116 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 5976 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2000 | 79 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 4213 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 8491 | 0.010 |
Why?
|
| Clathrin | 1 | 2000 | 29 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 736 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 11352 | 0.010 |
Why?
|
| Point Mutation | 1 | 2000 | 246 | 0.010 |
Why?
|
| Male | 2 | 2014 | 40967 | 0.010 |
Why?
|
| Endocytosis | 1 | 2000 | 177 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 557 | 0.010 |
Why?
|
| Peptides | 1 | 2002 | 639 | 0.010 |
Why?
|
| Cell Line | 1 | 2002 | 2468 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 307 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1997 | 297 | 0.010 |
Why?
|
| Acute Disease | 1 | 1997 | 826 | 0.010 |
Why?
|
| Homeostasis | 1 | 1997 | 409 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 3968 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1997 | 971 | 0.010 |
Why?
|
| Insulin | 1 | 1997 | 1160 | 0.010 |
Why?
|
| Rats | 1 | 1997 | 3990 | 0.010 |
Why?
|